ABSTRACT
Clostridium botulinum secretes a potent neurotoxin that causes devastating effects when ingested, including paralysis and death if not treated. In the United States, some clinically significant strains produce toxin type A while also harboring a silent B gene. These are the first two closed genome sequences published for this subset.
GENOME ANNOUNCEMENT
Many Clostridium botulinum type A strains isolated in the United States also harbor a silent toxin type B gene (bont/B) (our unpublished data). These strains have been difficult to distinguish by traditional subtyping methods, such as pulsed-field gel electrophoresis or multilocus variable-number tandem-repeat analysis (1–8). As whole-genome sequencing has become more accessible to public health laboratories, it is vital to have representative closed genome sequences for clinically relevant strain populations. Here, we present two finished genome sequences containing a bont/A1 gene and the unexpressed bont/B5 gene.
A hybrid assembly method was utilized, and both isolates were sequenced by Illumina and PacBio and then assembled using Velvet 1.2.08, HGAP 3, and Phrap 4.24. The coverages for strain CDC69094 were 263× by PacBio and 309× by Illumina. The coverages for strain CDC67190 were 334× by PacBio and 310× by Illumina.
CDC67190 was isolated from patient stool in the course of a foodborne outbreak investigation. The finished genome included 2 plasmids, pNPD12_1 (accession no. CP014146), with 5,926 bp, and pNPD12_2 (accession no. CP014147), with 59,360 bp. These plasmids contain 6 and 109 coding regions, respectively. The chromosome has 3,954,777 bp and includes 3,602 coding regions and a G+C content of 28.2%. Both toxin genes were found in the chromosome rather than on the plasmids.
CDC69094 was isolated from a stool specimen from an infant botulism case. Interestingly, this genome did not include a plasmid, indicating that the unexpressed B gene is contained on the chromosome with the toxin type A gene. The chromosome (accession no. CP013246) included 4,089,027 bp, a G+C content of 28.1%, and 3,711 coding regions.
Accession number(s).
The finished sequences have been deposited in GenBank, under accession no. CP013246 for CDC69094 and accession numbers CP014146, CP014147, and CP014148 for CDC67190.
ACKNOWLEDGMENTS
Support for this project was provided by the CDC Office of Public Health Preparedness and Response. T.B.S. was supported by an Oak Ridge Institute for Science and Education postdoctoral fellowship.
The findings and conclusions in this report are those of the author and do not represent the official position of the Centers for Disease Control and Prevention.
Footnotes
Citation Halpin JL, Hill K, Johnson SL, Bruce DC, Shirey TB, Dykes JK, Lúquez C. 2017. Finished whole-genome sequences of two Clostridium botulinum type A(B) isolates. Genome Announc 5:e00381-17. https://doi.org/10.1128/genomeA.00381-17.
REFERENCES
- 1.Raphael BH, Luquez C, McCroskey LM, Joseph LA, Jacobson MJ, Johnson EA, Maslanka SE, Andreadis JD. 2008. Genetic homogeneity of Clostridium botulinum type A1 strains with unique toxin gene clusters. Appl Environ Microbiol 74:4390–4397. doi: 10.1128/AEM.00260-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Raphael BH, Shirey TB, Lúquez C, Maslanka SE. 2014. Distinguishing highly-related outbreak-associated Clostridium botulinum type A(B) strains. BMC Microbiol 14:192. doi: 10.1186/1471-2180-14-192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Smith TJ, Hill KK, Raphael BH. 2015. Historical and current perspectives on Clostridium botulinum diversity. Res Microbiol 166:290–302. doi: 10.1016/j.resmic.2014.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Jacobson MJ, Lin G, Whittam TS, Johnson EA. 2008. Phylogenetic analysis of Clostridium botulinum type A by multi-locus sequence typing. Microbiology 154:2408–2415. doi: 10.1099/mic.0.2008/016915-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hutson RA, Zhou Y, Collins MD, Johnson EA, Hatheway CL, Sugiyama H. 1996. Genetic characterization of Clostridium botulinum type A containing silent type B neurotoxin gene sequences. J Biol Chem 271:10786–10792. doi: 10.1074/jbc.271.18.10786. [DOI] [PubMed] [Google Scholar]
- 6.Franciosa G, Maugliani A, Scalfaro C, Aureli P. 2009. Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains. PLoS One 4:e4829. doi: 10.1371/journal.pone.0004829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gonzalez-Escalona N, Timme R, Raphael BH, Zink D, Sharma SK. 2014. Whole-genome single-nucleotide-polymorphism analysis for discrimination of Clostridium botulinum group I strains. Appl Environ Microbiol 80:2125–2132. doi: 10.1128/AEM.03934-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Collins MD, East AK. 1998. Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins. J Appl Microbiol 84:5–17. doi: 10.1046/j.1365-2672.1997.00313.x. [DOI] [PubMed] [Google Scholar]